Tool Create startup animated videos in minutes, not in hours! 

 4 days ago

Nura Bio Launches with $73M in Series A

Quick Summary

Nura Bio Launches with $73M in Series A Back to HomeSOUTH SAN FRANCISCO, CA, Nura Bio announced its official launch and a $73 million Series A round led by the Column Group. Nura Bio Inc., a biopharma company created to discover and develop life-changing neuroprotective drugs, today announced its official launch. Alpna Seth, PhD, a leader in the global biotechnology industry, is President and Chief Executive Officer of Nura Bio. Prior to joining Nura Bio, Dr. Seth was Chief Operating Officer of Vir Biotechnology. In addition to Nura Bio, she serves on the boards of Seattle Genetics (NASDAQ:SGEN) and Bio Techne (NASDAQ:TECH).

Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Read Original Article

Popular Topics

Get the best stories from Startup Around on Telegram